US 11285210
Buffer formulations for enhanced antibody stability
granted A61KA61K2039/54A61K39/39591
Quick answer
US patent 11285210 (Buffer formulations for enhanced antibody stability) held by Outlook Therapeutics, Inc. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Outlook Therapeutics, Inc.
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/54, A61K39/39591, A61K47/12, A61K47/183